市場調査レポート

商品コード

1109894

世界のリナクロチド原薬市場：考察と予測 (2028年まで)

Global Linaclotide API Market Insights, Forecast to 2028

出版日: 2022年08月08日 | 発行: QYResearch

| ページ情報: 英文 114 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　詳細はお問い合わせください。

価格

PDF (Single User License)

USD 4,900 763,224円

レポートPDFを1名のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペースト可能です。PDFの印刷は何回でも可能ですが、印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (Multi User License)

USD 7,350 1,144,836円

レポートPDFを5名までご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペースト可能です。PDFの印刷は何回でも可能ですが、印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (Enterprise User License)

USD 9,800 1,526,448円

レポートPDFを企業内すべての方にご使用頂けるライセンスです。PDF内のテキスト等のコピー＆ペースト可能です。PDFの印刷は何回でも可能ですが、印刷したもののご利用はPDFのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=155.76円

ご注意事項 :

本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

当レポートは、リナクロチド原薬 (Linaclotide API) 市場について調査しており、市場規模や動向・需要の予測、成長要因および課題の分析、タイプ・用途・企業・地域別の内訳、競合情勢、主要企業のプロファイルなどの情報を提供しています。

リナクロチド原薬の製品概要
市場：純度別
- 世界のリナクロチド原薬市場規模：純度別, 2017 VS 2021 VS 2028
- 0.98
- 0.99
- Others
市場：アプリケーション別
- 世界のリナクロチド原薬市場規模：アプリケーション別, 2017 VS 2021 VS 2028
- Tablets
- Capsules
- Others
調査目的
対象期間

第2章世界のリナクロチド原薬の生産

世界のリナクロチド原薬の生産能力 (2017-2028)
世界のリナクロチド原薬の生産：地域別: 2017 VS 2021 VS 2028
世界のリナクロチド原薬の生産：地域別
- 世界のリナクロチド原薬の生産実績：地域別 (2017-2022)
- 世界のリナクロチド原薬の生産予測：地域別 (2023-2028)
北米
欧州
中国
日本

第3章世界のリナクロチド原薬の販売（数量・金額）推定および予測

世界のリナクロチド原薬の販売推定および予測 2017-2028
世界のリナクロチド原薬の収益推定および予測 2017-2028
世界のリナクロチド原薬の収益：地域別: 2017 VS 2021 VS 2028
世界のリナクロチド原薬の販売：地域別
- 世界のリナクロチド原薬の販売：地域別 (2017-2022)
- 世界の販売リナクロチド原薬：地域別 (2023-2028)
世界のリナクロチド原薬の収益：地域別
- 世界のリナクロチド原薬の収益：地域別 (2017-2022)
- 世界のリナクロチド原薬の収益：地域別 (2023-2028)
北米
欧州
アジア太平洋地域
ラテンアメリカ
中東・アフリカ

第4章競合：メーカー別

世界のリナクロチド原薬の生産能力：メーカー別
世界のリナクロチド原薬の販売：メーカー別
- 世界のリナクロチド原薬の販売：メーカー別 (2017-2022)
- 世界のリナクロチド原薬の販売市場シェア：メーカー別 (2017-2022)
- 世界の上位10・上位5メーカー：リナクロチド原薬2021
世界のリナクロチド原薬の収益：メーカー別
- 世界のリナクロチド原薬の収益：メーカー別 (2017-2022)
- 世界のリナクロチド原薬の収益市場シェア：メーカー別 (2017-2022)
- 世界の上位10・上位5企業：リナクロチド原薬の収益 2021
世界のリナクロチド原薬の販売価格：メーカー別
競合情勢の分析
- メーカーの市場集中度 (CR5 and HHI)
- 世界のリナクロチド原薬の市場シェア：企業タイプ別 (Tier 1, Tier 2, and Tier 3)
- 世界のリナクロチド原薬のメーカーの地理的分布
M&A, 拡張計画

第5章市場規模：純度別

世界のリナクロチド原薬の販売：純度別
- 世界のリナクロチド原薬の販売実績：純度別 (2017-2022)
- 世界のリナクロチド原薬の販売予測：純度別 (2023-2028)
- 世界のリナクロチド原薬の販売市場シェア：純度別 (2017-2028)
世界のリナクロチド原薬の収益：純度別
- 世界のリナクロチド原薬の収益実績：純度別 (2017-2022)
- 世界のリナクロチド原薬の収益予測：純度別 (2023-2028)
- 世界のリナクロチド原薬の収益シェア：純度別 (2017-2028)
世界のリナクロチド原薬の価格：純度別
- 世界のリナクロチド原薬の価格：純度別 (2017-2022)
- 世界のリナクロチド原薬の価格予測：純度別 (2023-2028)

第6章市場規模：アプリケーション別

世界のリナクロチド原薬の販売：アプリケーション別
- 世界のリナクロチド原薬の販売実績：アプリケーション別 (2017-2022)
- 世界のリナクロチド原薬の販売予測：アプリケーション別 (2023-2028)
- 世界のリナクロチド原薬の販売市場シェア：アプリケーション別 (2017-2028)
世界のリナクロチド原薬の収益：アプリケーション別
- 世界のリナクロチド原薬の収益実績：アプリケーション別 (2017-2022)
- 世界のリナクロチド原薬の収益予測：アプリケーション別 (2023-2028)
- 世界のリナクロチド原薬の収益市場シェア：アプリケーション別 (2017-2028)
世界のリナクロチド原薬の価格：アプリケーション別
- 世界のリナクロチド原薬の価格：アプリケーション別 (2017-2022)
- 世界のリナクロチド原薬の価格予測：アプリケーション別 (2023-2028)

第7章北米

北米のリナクロチド原薬市場規模：純度別
- 北米のリナクロチド原薬の販売：純度別 (2017-2028)
- 北米のリナクロチド原薬の収益：純度別 (2017-2028)
北米のリナクロチド原薬市場規模：アプリケーション別
- 北米のリナクロチド原薬の販売：アプリケーション別 (2017-2028)
- 北米のリナクロチド原薬の収益：アプリケーション別 (2017-2028)
北米のリナクロチド原薬の販売：国別
- 北米のリナクロチド原薬の販売：国別 (2017-2028)
- 北米のリナクロチド原薬の収益：国別 (2017-2028)
- 米国
- カナダ

第8章欧州

欧州のリナクロチド原薬市場規模：純度別
- 欧州のリナクロチド原薬の販売：純度別 (2017-2028)
- 欧州のリナクロチド原薬の収益：純度別 (2017-2028)
欧州のリナクロチド原薬市場規模：アプリケーション別
- 欧州のリナクロチド原薬の販売：アプリケーション別 (2017-2028)
- 欧州のリナクロチド原薬の収益：アプリケーション別 (2017-2028)
欧州のリナクロチド原薬の販売：国別
- 欧州のリナクロチド原薬の販売：国別 (2017-2028)
- 欧州のリナクロチド原薬の収益：国別 (2017-2028)
- ドイツ
- フランス
- 英国
- イタリア
- ロシア

第9章アジア太平洋

アジア太平洋のリナクロチド原薬市場規模：純度別
- アジア太平洋のリナクロチド原薬の販売：純度別 (2017-2028)
- アジア太平洋のリナクロチド原薬の収益：純度別 (2017-2028)
アジア太平洋のリナクロチド原薬市場規模：アプリケーション別
- アジア太平洋のリナクロチド原薬の販売：アプリケーション別 (2017-2028)
- アジア太平洋のリナクロチド原薬の収益：アプリケーション別 (2017-2028)
アジア太平洋のリナクロチド原薬の販売：地域別
- アジア太平洋のリナクロチド原薬の販売：地域別 (2017-2028)
- アジア太平洋のリナクロチド原薬の収益：地域別 (2017-2028)
- 中国
- 日本
- 韓国
- インド
- オーストラリア
- 台湾
- インドネシア
- タイ
- マレーシア

第10章ラテンアメリカ

ラテンアメリカのリナクロチド原薬市場規模：純度別
- ラテンアメリカのリナクロチド原薬の販売：純度別 (2017-2028)
- ラテンアメリカのリナクロチド原薬の収益：純度別 (2017-2028)
ラテンアメリカのリナクロチド原薬市場規模：アプリケーション別
- ラテンアメリカのリナクロチド原薬の販売：アプリケーション別 (2017-2028)
- ラテンアメリカのリナクロチド原薬の収益：アプリケーション別 (2017-2028)
ラテンアメリカのリナクロチド原薬の販売：国別
- ラテンアメリカのリナクロチド原薬の販売：国別 (2017-2028)
- ラテンアメリカのリナクロチド原薬の収益：国別 (2017-2028)
- メキシコ
- ブラジル
- アルゼンチン
- コロンビア

第11章中東・アフリカ

中東・アフリカのリナクロチド原薬市場規模：純度別
- 中東・アフリカのリナクロチド原薬の販売：純度別 (2017-2028)
- 中東・アフリカのリナクロチド原薬の収益：純度別 (2017-2028)
中東・アフリカのリナクロチド原薬市場規模：アプリケーション別
- 中東・アフリカのリナクロチド原薬の販売：アプリケーション別 (2017-2028)
- 中東・アフリカのリナクロチド原薬の収益：アプリケーション別 (2017-2028)
中東・アフリカのリナクロチド原薬の販売：国別
- 中東・アフリカのリナクロチド原薬の販売：国別 (2017-2028)
- 中東・アフリカのリナクロチド原薬の収益：国別 (2017-2028)
- トルコ
- サウジアラビア
- UAE

第12章企業プロファイル

Suzhou Tianma Pharma Group
Guangzhou Tosun Pharmaceutical
Neuland
Piramal Pharma Solutions
Teva API
ChemWerth
Rochem
Zeon-Health Industries
Omgene
USV
Anthem Biosciences
BCN Peptides
Biocon
MSN Labs

第13章業界チェーンと販売チャネルの分析

リナクロチド原薬業界チェーン分析
リナクロチド原薬主要原材料分析
- 主要原材料分析
- 原材料の主要サプライヤー
リナクロチド原薬生産形態とプロセス
リナクロチド原薬販売およびマーケティング
- リナクロチド原薬販売チャネル
- リナクロチド原薬卸業者
リナクロチド原薬顧客

第14章市場の促進要因, 機会, 課題とリスク要因の分析

リナクロチド原薬業界動向
リナクロチド原薬市場の促進要因
リナクロチド原薬市場の課題
リナクロチド原薬市場の抑制要因

第15章世界のリナクロチド原薬の主な市場調査結果

第16章付録

図表

List of Tables

Table 1. Global Linaclotide API Market Size Growth Rate by Purity, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of 0.98
Table 3. Major Manufacturers of 0.99
Table 4. Major Manufacturers of Others
Table 5. Global Linaclotide API Market Size Growth Rate by Application, 2017 VS 2021 2028 (US$ Million)
Table 6. Global Linaclotide API Production by Region: 2017 VS 2021 VS 2028 (Tons)
Table 7. Global Linaclotide API Production by Region (2017-2022) & (Tons)
Table 8. Global Linaclotide API Production Market Share by Region (2017-2022)
Table 9. Global Linaclotide API Production by Region (2023-2028) & (Tons)
Table 10. Global Linaclotide API Production Market Share by Region (2023-2028)
Table 11. Global Linaclotide API Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 12. Global Linaclotide API Sales by Region (2017-2022) & (Tons)
Table 13. Global Linaclotide API Sales Market Share by Region (2017-2022)
Table 14. Global Linaclotide API Sales by Region (2023-2028) & (Tons)
Table 15. Global Linaclotide API Sales Market Share by Region (2023-2028)
Table 16. Global Linaclotide API Revenue by Region (2017-2022) & (US$ Million)
Table 17. Global Linaclotide API Revenue Market Share by Region (2017-2022)
Table 18. Global Linaclotide API Revenue by Region (2023-2028) & (US$ Million)
Table 19. Global Linaclotide API Revenue Market Share by Region (2023-2028)
Table 20. Global Linaclotide API Production Capacity by Manufacturers (2017-2022) & (Tons)
Table 21. Global Linaclotide API Capacity Market Share by Manufacturers (2017-2022)
Table 22. Global Linaclotide API Sales by Manufacturers (2017-2022) & (Tons)
Table 23. Global Linaclotide API Sales Market Share by Manufacturers (2017-2022)
Table 24. Global Linaclotide API Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 25. Global Linaclotide API Revenue Share by Manufacturers (2017-2022)
Table 26. Linaclotide API Price by Manufacturers 2017-2022 (US$/Kg)
Table 27. Global Linaclotide API Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 28. Global Linaclotide API by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Linaclotide API as of 2021)
Table 29. Linaclotide API Manufacturing Base Distribution and Headquarters
Table 30. Manufacturers Linaclotide API Product Offered
Table 31. Date of Manufacturers Enter into Linaclotide API Market
Table 32. Mergers & Acquisitions, Expansion Plans
Table 33. Global Linaclotide API Sales by Purity (2017-2022) & (Tons)
Table 34. Global Linaclotide API Sales by Purity (2023-2028) & (Tons)
Table 35. Global Linaclotide API Sales Share by Purity (2017-2022)
Table 36. Global Linaclotide API Sales Share by Purity (2023-2028)
Table 37. Global Linaclotide API Revenue by Purity (2017-2022) & (US$ Million)
Table 38. Global Linaclotide API Revenue by Purity (2023-2028) & (US$ Million)
Table 39. Global Linaclotide API Revenue Share by Purity (2017-2022)
Table 40. Global Linaclotide API Revenue Share by Purity (2023-2028)
Table 41. Linaclotide API Price by Purity (2017-2022) & (US$/Kg)
Table 42. Global Linaclotide API Price Forecast by Purity (2023-2028) & (US$/Kg)
Table 43. Global Linaclotide API Sales by Application (2017-2022) & (Tons)
Table 44. Global Linaclotide API Sales by Application (2023-2028) & (Tons)
Table 45. Global Linaclotide API Sales Share by Application (2017-2022)
Table 46. Global Linaclotide API Sales Share by Application (2023-2028)
Table 47. Global Linaclotide API Revenue by Application (2017-2022) & (US$ Million)
Table 48. Global Linaclotide API Revenue by Application (2023-2028) & (US$ Million)
Table 49. Global Linaclotide API Revenue Share by Application (2017-2022)
Table 50. Global Linaclotide API Revenue Share by Application (2023-2028)
Table 51. Linaclotide API Price by Application (2017-2022) & (US$/Kg)
Table 52. Global Linaclotide API Price Forecast by Application (2023-2028) & (US$/Kg)
Table 53. North America Linaclotide API Sales by Purity (2017-2022) & (Tons)
Table 54. North America Linaclotide API Sales by Purity (2023-2028) & (Tons)
Table 55. North America Linaclotide API Revenue by Purity (2017-2022) & (US$ Million)
Table 56. North America Linaclotide API Revenue by Purity (2023-2028) & (US$ Million)
Table 57. North America Linaclotide API Sales by Application (2017-2022) & (Tons)
Table 58. North America Linaclotide API Sales by Application (2023-2028) & (Tons)
Table 59. North America Linaclotide API Revenue by Application (2017-2022) & (US$ Million)
Table 60. North America Linaclotide API Revenue by Application (2023-2028) & (US$ Million)
Table 61. North America Linaclotide API Sales by Country (2017-2022) & (Tons)
Table 62. North America Linaclotide API Sales by Country (2023-2028) & (Tons)
Table 63. North America Linaclotide API Revenue by Country (2017-2022) & (US$ Million)
Table 64. North America Linaclotide API Revenue by Country (2023-2028) & (US$ Million)
Table 65. Europe Linaclotide API Sales by Purity (2017-2022) & (Tons)
Table 66. Europe Linaclotide API Sales by Purity (2023-2028) & (Tons)
Table 67. Europe Linaclotide API Revenue by Purity (2017-2022) & (US$ Million)
Table 68. Europe Linaclotide API Revenue by Purity (2023-2028) & (US$ Million)
Table 69. Europe Linaclotide API Sales by Application (2017-2022) & (Tons)
Table 70. Europe Linaclotide API Sales by Application (2023-2028) & (Tons)
Table 71. Europe Linaclotide API Revenue by Application (2017-2022) & (US$ Million)
Table 72. Europe Linaclotide API Revenue by Application (2023-2028) & (US$ Million)
Table 73. Europe Linaclotide API Sales by Country (2017-2022) & (Tons)
Table 74. Europe Linaclotide API Sales by Country (2023-2028) & (Tons)
Table 75. Europe Linaclotide API Revenue by Country (2017-2022) & (US$ Million)
Table 76. Europe Linaclotide API Revenue by Country (2023-2028) & (US$ Million)
Table 77. Asia Pacific Linaclotide API Sales by Purity (2017-2022) & (Tons)
Table 78. Asia Pacific Linaclotide API Sales by Purity (2023-2028) & (Tons)
Table 79. Asia Pacific Linaclotide API Revenue by Purity (2017-2022) & (US$ Million)
Table 80. Asia Pacific Linaclotide API Revenue by Purity (2023-2028) & (US$ Million)
Table 81. Asia Pacific Linaclotide API Sales by Application (2017-2022) & (Tons)
Table 82. Asia Pacific Linaclotide API Sales by Application (2023-2028) & (Tons)
Table 83. Asia Pacific Linaclotide API Revenue by Application (2017-2022) & (US$ Million)
Table 84. Asia Pacific Linaclotide API Revenue by Application (2023-2028) & (US$ Million)
Table 85. Asia Pacific Linaclotide API Sales by Region (2017-2022) & (Tons)
Table 86. Asia Pacific Linaclotide API Sales by Region (2023-2028) & (Tons)
Table 87. Asia Pacific Linaclotide API Revenue by Region (2017-2022) & (US$ Million)
Table 88. Asia Pacific Linaclotide API Revenue by Region (2023-2028) & (US$ Million)
Table 89. Latin America Linaclotide API Sales by Purity (2017-2022) & (Tons)
Table 90. Latin America Linaclotide API Sales by Purity (2023-2028) & (Tons)
Table 91. Latin America Linaclotide API Revenue by Purity (2017-2022) & (US$ Million)
Table 92. Latin America Linaclotide API Revenue by Purity (2023-2028) & (US$ Million)
Table 93. Latin America Linaclotide API Sales by Application (2017-2022) & (Tons)
Table 94. Latin America Linaclotide API Sales by Application (2023-2028) & (Tons)
Table 95. Latin America Linaclotide API Revenue by Application (2017-2022) & (US$ Million)
Table 96. Latin America Linaclotide API Revenue by Application (2023-2028) & (US$ Million)
Table 97. Latin America Linaclotide API Sales by Country (2017-2022) & (Tons)
Table 98. Latin America Linaclotide API Sales by Country (2023-2028) & (Tons)
Table 99. Latin America Linaclotide API Revenue by Country (2017-2022) & (US$ Million)
Table 100. Latin America Linaclotide API Revenue by Country (2023-2028) & (US$ Million)
Table 101. Middle East and Africa Linaclotide API Sales by Purity (2017-2022) & (Tons)
Table 102. Middle East and Africa Linaclotide API Sales by Purity (2023-2028) & (Tons)
Table 103. Middle East and Africa Linaclotide API Revenue by Purity (2017-2022) & (US$ Million)
Table 104. Middle East and Africa Linaclotide API Revenue by Purity (2023-2028) & (US$ Million)
Table 105. Middle East and Africa Linaclotide API Sales by Application (2017-2022) & (Tons)
Table 106. Middle East and Africa Linaclotide API Sales by Application (2023-2028) & (Tons)
Table 107. Middle East and Africa Linaclotide API Revenue by Application (2017-2022) & (US$ Million)
Table 108. Middle East and Africa Linaclotide API Revenue by Application (2023-2028) & (US$ Million)
Table 109. Middle East and Africa Linaclotide API Sales by Country (2017-2022) & (Tons)
Table 110. Middle East and Africa Linaclotide API Sales by Country (2023-2028) & (Tons)
Table 111. Middle East and Africa Linaclotide API Revenue by Country (2017-2022) & (US$ Million)
Table 112. Middle East and Africa Linaclotide API Revenue by Country (2023-2028) & (US$ Million)
Table 113. Suzhou Tianma Pharma Group Corporation Information
Table 114. Suzhou Tianma Pharma Group Description and Major Businesses
Table 115. Suzhou Tianma Pharma Group Linaclotide API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 116. Suzhou Tianma Pharma Group Linaclotide API Product Model Numbers, Pictures, Descriptions and Specifications
Table 117. Suzhou Tianma Pharma Group Recent Development
Table 118. Guangzhou Tosun Pharmaceutical Corporation Information
Table 119. Guangzhou Tosun Pharmaceutical Description and Major Businesses
Table 120. Guangzhou Tosun Pharmaceutical Linaclotide API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 121. Guangzhou Tosun Pharmaceutical Linaclotide API Product Model Numbers, Pictures, Descriptions and Specifications
Table 122. Guangzhou Tosun Pharmaceutical Recent Development
Table 123. Neuland Corporation Information
Table 124. Neuland Description and Major Businesses
Table 125. Neuland Linaclotide API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 126. Neuland Linaclotide API Product Model Numbers, Pictures, Descriptions and Specifications
Table 127. Neuland Recent Development
Table 128. Piramal Pharma Solutions Corporation Information
Table 129. Piramal Pharma Solutions Description and Major Businesses
Table 130. Piramal Pharma Solutions Linaclotide API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 131. Piramal Pharma Solutions Linaclotide API Product Model Numbers, Pictures, Descriptions and Specifications
Table 132. Piramal Pharma Solutions Recent Development
Table 133. Teva API Corporation Information
Table 134. Teva API Description and Major Businesses
Table 135. Teva API Linaclotide API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 136. Teva API Linaclotide API Product Model Numbers, Pictures, Descriptions and Specifications
Table 137. Teva API Recent Development
Table 138. ChemWerth Corporation Information
Table 139. ChemWerth Description and Major Businesses
Table 140. ChemWerth Linaclotide API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 141. ChemWerth Linaclotide API Product Model Numbers, Pictures, Descriptions and Specifications
Table 142. ChemWerth Recent Development
Table 143. Rochem Corporation Information
Table 144. Rochem Description and Major Businesses
Table 145. Rochem Linaclotide API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 146. Rochem Linaclotide API Product Model Numbers, Pictures, Descriptions and Specifications
Table 147. Rochem Recent Development
Table 148. Zeon-Health Industries Corporation Information
Table 149. Zeon-Health Industries Description and Major Businesses
Table 150. Zeon-Health Industries Linaclotide API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 151. Zeon-Health Industries Linaclotide API Product Model Numbers, Pictures, Descriptions and Specifications
Table 152. Zeon-Health Industries Recent Development
Table 153. Omgene Corporation Information
Table 154. Omgene Description and Major Businesses
Table 155. Omgene Linaclotide API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 156. Omgene Linaclotide API Product Model Numbers, Pictures, Descriptions and Specifications
Table 157. Omgene Recent Development
Table 158. USV Corporation Information
Table 159. USV Description and Major Businesses
Table 160. USV Linaclotide API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 161. USV Linaclotide API Product Model Numbers, Pictures, Descriptions and Specifications
Table 162. USV Recent Development
Table 163. Anthem Biosciences Corporation Information
Table 164. Anthem Biosciences Description and Major Businesses
Table 165. Anthem Biosciences Linaclotide API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 166. Anthem Biosciences Linaclotide API Product Model Numbers, Pictures, Descriptions and Specifications
Table 167. Anthem Biosciences Recent Development
Table 168. BCN Peptides Corporation Information
Table 169. BCN Peptides Description and Major Businesses
Table 170. BCN Peptides Linaclotide API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 171. BCN Peptides Linaclotide API Product Model Numbers, Pictures, Descriptions and Specifications
Table 172. BCN Peptides Recent Development
Table 173. Biocon Corporation Information
Table 174. Biocon Description and Major Businesses
Table 175. Biocon Linaclotide API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 176. Biocon Linaclotide API Product Model Numbers, Pictures, Descriptions and Specifications
Table 177. Biocon Recent Development
Table 178. MSN Labs Corporation Information
Table 179. MSN Labs Description and Major Businesses
Table 180. MSN Labs Linaclotide API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 181. MSN Labs Linaclotide API Product Model Numbers, Pictures, Descriptions and Specifications
Table 182. MSN Labs Recent Development
Table 183. Key Raw Materials Lists
Table 184. Raw Materials Key Suppliers Lists
Table 185. Linaclotide API Distributors List
Table 186. Linaclotide API Customers List
Table 187. Linaclotide API Market Trends
Table 188. Linaclotide API Market Drivers
Table 189. Linaclotide API Market Challenges
Table 190. Linaclotide API Market Restraints
Table 191. Research Programs/Design for This Report
Table 192. Key Data Information from Secondary Sources
Table 193. Key Data Information from Primary Sources

List of Figures

Figure 1. Linaclotide API Product Picture
Figure 2. Global Linaclotide API Market Share by Purity in 2021 & 2028
Figure 3. 0.98 Product Picture
Figure 4. 0.99 Product Picture
Figure 5. Others Product Picture
Figure 6. Global Linaclotide API Market Share by Application in 2021 & 2028
Figure 7. Tablets
Figure 8. Capsules
Figure 9. Others
Figure 10. Linaclotide API Report Years Considered
Figure 11. Global Linaclotide API Capacity, Production and Utilization (2017-2028) & (Tons)
Figure 12. Global Linaclotide API Production Market Share by Region in Percentage: 2021 Versus 2028
Figure 13. Global Linaclotide API Production Market Share by Region (2017-2022)
Figure 14. Global Linaclotide API Production Market Share by Region (2023-2028)
Figure 15. Linaclotide API Production Growth Rate in North America (2017-2028) & (Tons)
Figure 16. Linaclotide API Production Growth Rate in Europe (2017-2028) & (Tons)
Figure 17. Linaclotide API Production Growth Rate in China (2017-2028) & (Tons)
Figure 18. Linaclotide API Production Growth Rate in Japan (2017-2028) & (Tons)
Figure 19. Global Linaclotide API Sales 2017-2028 (Tons)
Figure 20. Global Linaclotide API Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 21. Global Linaclotide API Revenue 2017-2028 (US$ Million)
Figure 22. Global Linaclotide API Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 23. Global Linaclotide API Sales Market Share by Region (2017-2022)
Figure 24. Global Linaclotide API Sales Market Share by Region (2023-2028)
Figure 25. North America Linaclotide API Sales YoY (2017-2028) & (Tons)
Figure 26. North America Linaclotide API Revenue YoY (2017-2028) & (US$ Million)
Figure 27. Europe Linaclotide API Sales YoY (2017-2028) & (Tons)
Figure 28. Europe Linaclotide API Revenue YoY (2017-2028) & (US$ Million)
Figure 29. Asia-Pacific Linaclotide API Sales YoY (2017-2028) & (Tons)
Figure 30. Asia-Pacific Linaclotide API Revenue YoY (2017-2028) & (US$ Million)
Figure 31. Latin America Linaclotide API Sales YoY (2017-2028) & (Tons)
Figure 32. Latin America Linaclotide API Revenue YoY (2017-2028) & (US$ Million)
Figure 33. Middle East & Africa Linaclotide API Sales YoY (2017-2028) & (Tons)
Figure 34. Middle East & Africa Linaclotide API Revenue YoY (2017-2028) & (US$ Million)
Figure 35. The Linaclotide API Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 36. The Top 5 and 10 Largest Manufacturers of Linaclotide API in the World: Market Share by Linaclotide API Revenue in 2021
Figure 37. Linaclotide API Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 38. Global Linaclotide API Sales Market Share by Purity (2017-2028)
Figure 39. Global Linaclotide API Revenue Market Share by Purity (2017-2028)
Figure 40. Global Linaclotide API Sales Market Share by Application (2017-2028)
Figure 41. Global Linaclotide API Revenue Market Share by Application (2017-2028)
Figure 42. North America Linaclotide API Sales Market Share by Purity (2017-2028)
Figure 43. North America Linaclotide API Revenue Market Share by Purity (2017-2028)
Figure 44. North America Linaclotide API Sales Market Share by Application (2017-2028)
Figure 45. North America Linaclotide API Revenue Market Share by Application (2017-2028)
Figure 46. North America Linaclotide API Sales Share by Country (2017-2028)
Figure 47. North America Linaclotide API Revenue Share by Country (2017-2028)
Figure 48. United States Linaclotide API Revenue (2017-2028) & (US$ Million)
Figure 49. Canada Linaclotide API Revenue (2017-2028) & (US$ Million)
Figure 50. Europe Linaclotide API Sales Market Share by Purity (2017-2028)
Figure 51. Europe Linaclotide API Revenue Market Share by Purity (2017-2028)
Figure 52. Europe Linaclotide API Sales Market Share by Application (2017-2028)
Figure 53. Europe Linaclotide API Revenue Market Share by Application (2017-2028)
Figure 54. Europe Linaclotide API Sales Share by Country (2017-2028)
Figure 55. Europe Linaclotide API Revenue Share by Country (2017-2028)
Figure 56. Germany Linaclotide API Revenue (2017-2028) & (US$ Million)
Figure 57. France Linaclotide API Revenue (2017-2028) & (US$ Million)
Figure 58. U.K. Linaclotide API Revenue (2017-2028) & (US$ Million)
Figure 59. Italy Linaclotide API Revenue (2017-2028) & (US$ Million)
Figure 60. Russia Linaclotide API Revenue (2017-2028) & (US$ Million)
Figure 61. Asia Pacific Linaclotide API Sales Market Share by Purity (2017-2028)
Figure 62. Asia Pacific Linaclotide API Revenue Market Share by Purity (2017-2028)
Figure 63. Asia Pacific Linaclotide API Sales Market Share by Application (2017-2028)
Figure 64. Asia Pacific Linaclotide API Revenue Market Share by Application (2017-2028)
Figure 65. Asia Pacific Linaclotide API Sales Share by Region (2017-2028)
Figure 66. Asia Pacific Linaclotide API Revenue Share by Region (2017-2028)
Figure 67. China Linaclotide API Revenue (2017-2028) & (US$ Million)
Figure 68. Japan Linaclotide API Revenue (2017-2028) & (US$ Million)
Figure 69. South Korea Linaclotide API Revenue (2017-2028) & (US$ Million)
Figure 70. India Linaclotide API Revenue (2017-2028) & (US$ Million)
Figure 71. Australia Linaclotide API Revenue (2017-2028) & (US$ Million)
Figure 72. China Taiwan Linaclotide API Revenue (2017-2028) & (US$ Million)
Figure 73. Indonesia Linaclotide API Revenue (2017-2028) & (US$ Million)
Figure 74. Thailand Linaclotide API Revenue (2017-2028) & (US$ Million)
Figure 75. Malaysia Linaclotide API Revenue (2017-2028) & (US$ Million)
Figure 76. Latin America Linaclotide API Sales Market Share by Purity (2017-2028)
Figure 77. Latin America Linaclotide API Revenue Market Share by Purity (2017-2028)
Figure 78. Latin America Linaclotide API Sales Market Share by Application (2017-2028)
Figure 79. Latin America Linaclotide API Revenue Market Share by Application (2017-2028)
Figure 80. Latin America Linaclotide API Sales Share by Country (2017-2028)
Figure 81. Latin America Linaclotide API Revenue Share by Country (2017-2028)
Figure 82. Mexico Linaclotide API Revenue (2017-2028) & (US$ Million)
Figure 83. Brazil Linaclotide API Revenue (2017-2028) & (US$ Million)
Figure 84. Argentina Linaclotide API Revenue (2017-2028) & (US$ Million)
Figure 85. Colombia Linaclotide API Revenue (2017-2028) & (US$ Million)
Figure 86. Middle East and Africa Linaclotide API Sales Market Share by Purity (2017-2028)
Figure 87. Middle East and Africa Linaclotide API Revenue Market Share by Purity (2017-2028)
Figure 88. Middle East and Africa Linaclotide API Sales Market Share by Application (2017-2028)
Figure 89. Middle East and Africa Linaclotide API Revenue Market Share by Application (2017-2028)
Figure 90. Middle East and Africa Linaclotide API Sales Share by Country (2017-2028)
Figure 91. Middle East and Africa Linaclotide API Revenue Share by Country (2017-2028)
Figure 92. Turkey Linaclotide API Revenue (2017-2028) & (US$ Million)
Figure 93. Saudi Arabia Linaclotide API Revenue (2017-2028) & (US$ Million)
Figure 94. UAE Linaclotide API Revenue (2017-2028) & (US$ Million)
Figure 95. Linaclotide API Value Chain
Figure 96. Linaclotide API Production Process
Figure 97. Channels of Distribution
Figure 98. Distributors Profiles
Figure 99. Bottom-up and Top-down Approaches for This Report
Figure 100. Data Triangulation
Figure 101. Key Executives Interviewed

This research report focuses on the Linaclotide API Market. It analyzes market size, trends and demand forecasts, as well as growth factors and challenges. The report provides market data breakdowns by type, application, company, and region, in addition to competitive landscape and key company profiles.

1 Study Coverage

1.1 Linaclotide API Product Introduction
1.2 Market by Purity
- 1.2.1 Global Linaclotide API Market Size by Purity, 2017 VS 2021 VS 2028
- 1.2.2 0.98
- 1.2.3 0.99
- 1.2.4 Others
1.3 Market by Application
- 1.3.1 Global Linaclotide API Market Size by Application, 2017 VS 2021 VS 2028
- 1.3.2 Tablets
- 1.3.3 Capsules
- 1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Linaclotide API Production

2.1 Global Linaclotide API Production Capacity (2017-2028)
2.2 Global Linaclotide API Production by Region: 2017 VS 2021 VS 2028
2.3 Global Linaclotide API Production by Region
- 2.3.1 Global Linaclotide API Historic Production by Region (2017-2022)
- 2.3.2 Global Linaclotide API Forecasted Production by Region (2023-2028)
2.4 North America
2.5 Europe
2.6 China
2.7 Japan

3 Global Linaclotide API Sales in Volume & Value Estimates and Forecasts

3.1 Global Linaclotide API Sales Estimates and Forecasts 2017-2028
3.2 Global Linaclotide API Revenue Estimates and Forecasts 2017-2028
3.3 Global Linaclotide API Revenue by Region: 2017 VS 2021 VS 2028
3.4 Global Linaclotide API Sales by Region
- 3.4.1 Global Linaclotide API Sales by Region (2017-2022)
- 3.4.2 Global Sales Linaclotide API by Region (2023-2028)
3.5 Global Linaclotide API Revenue by Region
- 3.5.1 Global Linaclotide API Revenue by Region (2017-2022)
- 3.5.2 Global Linaclotide API Revenue by Region (2023-2028)
3.6 North America
3.7 Europe
3.8 Asia-Pacific
3.9 Latin America
3.10 Middle East & Africa

4 Competition by Manufactures

4.1 Global Linaclotide API Production Capacity by Manufacturers
4.2 Global Linaclotide API Sales by Manufacturers
- 4.2.1 Global Linaclotide API Sales by Manufacturers (2017-2022)
- 4.2.2 Global Linaclotide API Sales Market Share by Manufacturers (2017-2022)
- 4.2.3 Global Top 10 and Top 5 Largest Manufacturers of Linaclotide API in 2021
4.3 Global Linaclotide API Revenue by Manufacturers
- 4.3.1 Global Linaclotide API Revenue by Manufacturers (2017-2022)
- 4.3.2 Global Linaclotide API Revenue Market Share by Manufacturers (2017-2022)
- 4.3.3 Global Top 10 and Top 5 Companies by Linaclotide API Revenue in 2021
4.4 Global Linaclotide API Sales Price by Manufacturers
4.5 Analysis of Competitive Landscape
- 4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
- 4.5.2 Global Linaclotide API Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
- 4.5.3 Global Linaclotide API Manufacturers Geographical Distribution
4.6 Mergers & Acquisitions, Expansion Plans

5 Market Size by Purity

5.1 Global Linaclotide API Sales by Purity
- 5.1.1 Global Linaclotide API Historical Sales by Purity (2017-2022)
- 5.1.2 Global Linaclotide API Forecasted Sales by Purity (2023-2028)
- 5.1.3 Global Linaclotide API Sales Market Share by Purity (2017-2028)
5.2 Global Linaclotide API Revenue by Purity
- 5.2.1 Global Linaclotide API Historical Revenue by Purity (2017-2022)
- 5.2.2 Global Linaclotide API Forecasted Revenue by Purity (2023-2028)
- 5.2.3 Global Linaclotide API Revenue Market Share by Purity (2017-2028)
5.3 Global Linaclotide API Price by Purity
- 5.3.1 Global Linaclotide API Price by Purity (2017-2022)
- 5.3.2 Global Linaclotide API Price Forecast by Purity (2023-2028)

6 Market Size by Application

6.1 Global Linaclotide API Sales by Application
- 6.1.1 Global Linaclotide API Historical Sales by Application (2017-2022)
- 6.1.2 Global Linaclotide API Forecasted Sales by Application (2023-2028)
- 6.1.3 Global Linaclotide API Sales Market Share by Application (2017-2028)
6.2 Global Linaclotide API Revenue by Application
- 6.2.1 Global Linaclotide API Historical Revenue by Application (2017-2022)
- 6.2.2 Global Linaclotide API Forecasted Revenue by Application (2023-2028)
- 6.2.3 Global Linaclotide API Revenue Market Share by Application (2017-2028)
6.3 Global Linaclotide API Price by Application
- 6.3.1 Global Linaclotide API Price by Application (2017-2022)
- 6.3.2 Global Linaclotide API Price Forecast by Application (2023-2028)

7 North America

7.1 North America Linaclotide API Market Size by Purity
- 7.1.1 North America Linaclotide API Sales by Purity (2017-2028)
- 7.1.2 North America Linaclotide API Revenue by Purity (2017-2028)
7.2 North America Linaclotide API Market Size by Application
- 7.2.1 North America Linaclotide API Sales by Application (2017-2028)
- 7.2.2 North America Linaclotide API Revenue by Application (2017-2028)
7.3 North America Linaclotide API Sales by Country
- 7.3.1 North America Linaclotide API Sales by Country (2017-2028)
- 7.3.2 North America Linaclotide API Revenue by Country (2017-2028)
- 7.3.3 United States
- 7.3.4 Canada

8 Europe

8.1 Europe Linaclotide API Market Size by Purity
- 8.1.1 Europe Linaclotide API Sales by Purity (2017-2028)
- 8.1.2 Europe Linaclotide API Revenue by Purity (2017-2028)
8.2 Europe Linaclotide API Market Size by Application
- 8.2.1 Europe Linaclotide API Sales by Application (2017-2028)
- 8.2.2 Europe Linaclotide API Revenue by Application (2017-2028)
8.3 Europe Linaclotide API Sales by Country
- 8.3.1 Europe Linaclotide API Sales by Country (2017-2028)
- 8.3.2 Europe Linaclotide API Revenue by Country (2017-2028)
- 8.3.3 Germany
- 8.3.4 France
- 8.3.5 U.K.
- 8.3.6 Italy
- 8.3.7 Russia

9 Asia Pacific

9.1 Asia Pacific Linaclotide API Market Size by Purity
- 9.1.1 Asia Pacific Linaclotide API Sales by Purity (2017-2028)
- 9.1.2 Asia Pacific Linaclotide API Revenue by Purity (2017-2028)
9.2 Asia Pacific Linaclotide API Market Size by Application
- 9.2.1 Asia Pacific Linaclotide API Sales by Application (2017-2028)
- 9.2.2 Asia Pacific Linaclotide API Revenue by Application (2017-2028)
9.3 Asia Pacific Linaclotide API Sales by Region
- 9.3.1 Asia Pacific Linaclotide API Sales by Region (2017-2028)
- 9.3.2 Asia Pacific Linaclotide API Revenue by Region (2017-2028)
- 9.3.3 China
- 9.3.4 Japan
- 9.3.5 South Korea
- 9.3.6 India
- 9.3.7 Australia
- 9.3.8 China Taiwan
- 9.3.9 Indonesia
- 9.3.10 Thailand
- 9.3.11 Malaysia

10 Latin America

10.1 Latin America Linaclotide API Market Size by Purity
- 10.1.1 Latin America Linaclotide API Sales by Purity (2017-2028)
- 10.1.2 Latin America Linaclotide API Revenue by Purity (2017-2028)
10.2 Latin America Linaclotide API Market Size by Application
- 10.2.1 Latin America Linaclotide API Sales by Application (2017-2028)
- 10.2.2 Latin America Linaclotide API Revenue by Application (2017-2028)
10.3 Latin America Linaclotide API Sales by Country
- 10.3.1 Latin America Linaclotide API Sales by Country (2017-2028)
- 10.3.2 Latin America Linaclotide API Revenue by Country (2017-2028)
- 10.3.3 Mexico
- 10.3.4 Brazil
- 10.3.5 Argentina
- 10.3.6 Colombia

11 Middle East and Africa

11.1 Middle East and Africa Linaclotide API Market Size by Purity
- 11.1.1 Middle East and Africa Linaclotide API Sales by Purity (2017-2028)
- 11.1.2 Middle East and Africa Linaclotide API Revenue by Purity (2017-2028)
11.2 Middle East and Africa Linaclotide API Market Size by Application
- 11.2.1 Middle East and Africa Linaclotide API Sales by Application (2017-2028)
- 11.2.2 Middle East and Africa Linaclotide API Revenue by Application (2017-2028)
11.3 Middle East and Africa Linaclotide API Sales by Country
- 11.3.1 Middle East and Africa Linaclotide API Sales by Country (2017-2028)
- 11.3.2 Middle East and Africa Linaclotide API Revenue by Country (2017-2028)
- 11.3.3 Turkey
- 11.3.4 Saudi Arabia
- 11.3.5 UAE

12 Corporate Profiles

12.1 Suzhou Tianma Pharma Group
- 12.1.1 Suzhou Tianma Pharma Group Corporation Information
- 12.1.2 Suzhou Tianma Pharma Group Overview
- 12.1.3 Suzhou Tianma Pharma Group Linaclotide API Sales, Price, Revenue and Gross Margin (2017-2022)
- 12.1.4 Suzhou Tianma Pharma Group Linaclotide API Product Model Numbers, Pictures, Descriptions and Specifications
- 12.1.5 Suzhou Tianma Pharma Group Recent Developments
12.2 Guangzhou Tosun Pharmaceutical
- 12.2.1 Guangzhou Tosun Pharmaceutical Corporation Information
- 12.2.2 Guangzhou Tosun Pharmaceutical Overview
- 12.2.3 Guangzhou Tosun Pharmaceutical Linaclotide API Sales, Price, Revenue and Gross Margin (2017-2022)
- 12.2.4 Guangzhou Tosun Pharmaceutical Linaclotide API Product Model Numbers, Pictures, Descriptions and Specifications
- 12.2.5 Guangzhou Tosun Pharmaceutical Recent Developments
12.3 Neuland
- 12.3.1 Neuland Corporation Information
- 12.3.2 Neuland Overview
- 12.3.3 Neuland Linaclotide API Sales, Price, Revenue and Gross Margin (2017-2022)
- 12.3.4 Neuland Linaclotide API Product Model Numbers, Pictures, Descriptions and Specifications
- 12.3.5 Neuland Recent Developments
12.4 Piramal Pharma Solutions
- 12.4.1 Piramal Pharma Solutions Corporation Information
- 12.4.2 Piramal Pharma Solutions Overview
- 12.4.3 Piramal Pharma Solutions Linaclotide API Sales, Price, Revenue and Gross Margin (2017-2022)
- 12.4.4 Piramal Pharma Solutions Linaclotide API Product Model Numbers, Pictures, Descriptions and Specifications
- 12.4.5 Piramal Pharma Solutions Recent Developments
12.5 Teva API
- 12.5.1 Teva API Corporation Information
- 12.5.2 Teva API Overview
- 12.5.3 Teva API Linaclotide API Sales, Price, Revenue and Gross Margin (2017-2022)
- 12.5.4 Teva API Linaclotide API Product Model Numbers, Pictures, Descriptions and Specifications
- 12.5.5 Teva API Recent Developments
12.6 ChemWerth
- 12.6.1 ChemWerth Corporation Information
- 12.6.2 ChemWerth Overview
- 12.6.3 ChemWerth Linaclotide API Sales, Price, Revenue and Gross Margin (2017-2022)
- 12.6.4 ChemWerth Linaclotide API Product Model Numbers, Pictures, Descriptions and Specifications
- 12.6.5 ChemWerth Recent Developments
12.7 Rochem
- 12.7.1 Rochem Corporation Information
- 12.7.2 Rochem Overview
- 12.7.3 Rochem Linaclotide API Sales, Price, Revenue and Gross Margin (2017-2022)
- 12.7.4 Rochem Linaclotide API Product Model Numbers, Pictures, Descriptions and Specifications
- 12.7.5 Rochem Recent Developments
12.8 Zeon-Health Industries
- 12.8.1 Zeon-Health Industries Corporation Information
- 12.8.2 Zeon-Health Industries Overview
- 12.8.3 Zeon-Health Industries Linaclotide API Sales, Price, Revenue and Gross Margin (2017-2022)
- 12.8.4 Zeon-Health Industries Linaclotide API Product Model Numbers, Pictures, Descriptions and Specifications
- 12.8.5 Zeon-Health Industries Recent Developments
12.9 Omgene
- 12.9.1 Omgene Corporation Information
- 12.9.2 Omgene Overview
- 12.9.3 Omgene Linaclotide API Sales, Price, Revenue and Gross Margin (2017-2022)
- 12.9.4 Omgene Linaclotide API Product Model Numbers, Pictures, Descriptions and Specifications
- 12.9.5 Omgene Recent Developments
12.10 USV
- 12.10.1 USV Corporation Information
- 12.10.2 USV Overview
- 12.10.3 USV Linaclotide API Sales, Price, Revenue and Gross Margin (2017-2022)
- 12.10.4 USV Linaclotide API Product Model Numbers, Pictures, Descriptions and Specifications
- 12.10.5 USV Recent Developments
12.11 Anthem Biosciences
- 12.11.1 Anthem Biosciences Corporation Information
- 12.11.2 Anthem Biosciences Overview
- 12.11.3 Anthem Biosciences Linaclotide API Sales, Price, Revenue and Gross Margin (2017-2022)
- 12.11.4 Anthem Biosciences Linaclotide API Product Model Numbers, Pictures, Descriptions and Specifications
- 12.11.5 Anthem Biosciences Recent Developments
12.12 BCN Peptides
- 12.12.1 BCN Peptides Corporation Information
- 12.12.2 BCN Peptides Overview
- 12.12.3 BCN Peptides Linaclotide API Sales, Price, Revenue and Gross Margin (2017-2022)
- 12.12.4 BCN Peptides Linaclotide API Product Model Numbers, Pictures, Descriptions and Specifications
- 12.12.5 BCN Peptides Recent Developments
12.13 Biocon
- 12.13.1 Biocon Corporation Information
- 12.13.2 Biocon Overview
- 12.13.3 Biocon Linaclotide API Sales, Price, Revenue and Gross Margin (2017-2022)
- 12.13.4 Biocon Linaclotide API Product Model Numbers, Pictures, Descriptions and Specifications
- 12.13.5 Biocon Recent Developments
12.14 MSN Labs
- 12.14.1 MSN Labs Corporation Information
- 12.14.2 MSN Labs Overview
- 12.14.3 MSN Labs Linaclotide API Sales, Price, Revenue and Gross Margin (2017-2022)
- 12.14.4 MSN Labs Linaclotide API Product Model Numbers, Pictures, Descriptions and Specifications
- 12.14.5 MSN Labs Recent Developments

13 Industry Chain and Sales Channels Analysis

13.1 Linaclotide API Industry Chain Analysis
13.2 Linaclotide API Key Raw Materials
- 13.2.1 Key Raw Materials
- 13.2.2 Raw Materials Key Suppliers
13.3 Linaclotide API Production Mode & Process
13.4 Linaclotide API Sales and Marketing
- 13.4.1 Linaclotide API Sales Channels
- 13.4.2 Linaclotide API Distributors
13.5 Linaclotide API Customers

14 Market Drivers, Opportunities, Challenges and Risks Factors Analysis

14.1 Linaclotide API Industry Trends
14.2 Linaclotide API Market Drivers
14.3 Linaclotide API Market Challenges
14.4 Linaclotide API Market Restraints

15 Key Finding in The Global Linaclotide API Study

16 Appendix

16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

世界のリナクロチド原薬市場：考察と予測 (2028年まで)

Global Linaclotide API Market Insights, Forecast to 2028

目次

第1章調査対象

第2章世界のリナクロチド原薬の生産

第3章世界のリナクロチド原薬の販売（数量・金額）推定および予測

第4章競合：メーカー別

第5章市場規模：純度別

第6章市場規模：アプリケーション別

第7章北米

第8章欧州

第9章アジア太平洋

第10章ラテンアメリカ

第11章中東・アフリカ

第12章企業プロファイル

第13章業界チェーンと販売チャネルの分析

第14章市場の促進要因, 機会, 課題とリスク要因の分析

第15章世界のリナクロチド原薬の主な市場調査結果

第16章付録

List of Tables

List of Figures

TABLE OF CONTENTS

1 Study Coverage

2 Global Linaclotide API Production

3 Global Linaclotide API Sales in Volume & Value Estimates and Forecasts

4 Competition by Manufactures

5 Market Size by Purity

6 Market Size by Application

7 North America

8 Europe

9 Asia Pacific

10 Latin America

11 Middle East and Africa

12 Corporate Profiles

13 Industry Chain and Sales Channels Analysis

14 Market Drivers, Opportunities, Challenges and Risks Factors Analysis

15 Key Finding in The Global Linaclotide API Study

16 Appendix

世界のリナクロチド原薬市場：考察と予測 (2028年まで)

Global Linaclotide API Market Insights, Forecast to 2028

目次

第1章 調査対象

第2章 世界のリナクロチド原薬の生産

第3章 世界のリナクロチド原薬の販売（数量・金額）推定および予測

第4章 競合：メーカー別

第5章 市場規模：純度別

第6章 市場規模：アプリケーション別

第7章 北米

第8章 欧州

第9章 アジア太平洋

第10章 ラテンアメリカ

第11章 中東・アフリカ

第12章 企業プロファイル

第13章 業界チェーンと販売チャネルの分析

第14章 市場の促進要因, 機会, 課題とリスク要因の分析

第15章 世界のリナクロチド原薬の主な市場調査結果

第16章 付録

List of Tables

List of Figures

TABLE OF CONTENTS

1 Study Coverage

2 Global Linaclotide API Production

3 Global Linaclotide API Sales in Volume & Value Estimates and Forecasts

4 Competition by Manufactures

5 Market Size by Purity

6 Market Size by Application

7 North America

8 Europe

9 Asia Pacific

10 Latin America

11 Middle East and Africa

12 Corporate Profiles

13 Industry Chain and Sales Channels Analysis

14 Market Drivers, Opportunities, Challenges and Risks Factors Analysis

15 Key Finding in The Global Linaclotide API Study

16 Appendix

第1章調査対象

第2章世界のリナクロチド原薬の生産

第3章世界のリナクロチド原薬の販売（数量・金額）推定および予測

第4章競合：メーカー別

第5章市場規模：純度別

第6章市場規模：アプリケーション別

第7章北米

第8章欧州

第9章アジア太平洋

第10章ラテンアメリカ

第11章中東・アフリカ

第12章企業プロファイル

第13章業界チェーンと販売チャネルの分析

第14章市場の促進要因, 機会, 課題とリスク要因の分析

第15章世界のリナクロチド原薬の主な市場調査結果

第16章付録